Ignite Creation Date:
2024-05-06 @ 2:58 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04485780
Status:
UNKNOWN
Last Update Posted:
2020-07-24
First Post:
2020-07-21
Brief Title:
Botulinum Toxin Injection in Patients Undergoing Hemorrhoidectomy-A Prospective Randomized Study
Sponsor:
Tri-Service General Hospital
Organization:
Tri-Service General Hospital
Study Overview
Official Title:
The Optimal Timing of Botulinum Toxin Injection for Pain Control in Patients Undergoing Hemorrhoidectomy-A Prospective Randomized Study
Status:
UNKNOWN
Status Verified Date:
2020-07
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective randomized study which anticipatedly recruited 60 patients in the outpatient department who need hemorrhoidectomy from January 2019 to December 2019 After obtaining those patients consent in the clinic they were randomly assigned to two groups at a 11 ratio using a computer-generated list of random numbers Microsoft Excel One group received Botulinum toxin injection during the outpatient clinic one week before the operationexperimental group EG and the other group received injection during the operationcontrol group CG The two groups were compared for the influence of postoperative pain control and wound healing rate
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None